Studies have indicated that antigens like HER2, CEA, MUC1, Claudin 18.2 (CLDN 18.2), EpCAM, B7H3, MSLN, and NKG2D serve as effective targets for CAR-T cell therapy in gastric cancer [194]. Here, MSLN is linked to gastric cancer.